Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population

Indian Journal of Endocrinology and Metabolism

Volumn 19, Issue 1, 2015, Pages 77-83

  Bener, Abdulbari ^a,b   Zirie, M ^c   Al Hamaq, A O A A ^d   Nawaz, Z ^a   Samson, N ^a   Mohammad, R ^a,e  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c HAMAD GENERAL HOSPITAL   (Qatar)

^d QATAR FOUNDATION   (Qatar)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allele frequency; consanguinity; diabetes mellitus; obesity; PPAR 2 gene; Pro12Ala polymorphism

Indexed keywords

EID: 84981156670     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.131766     Document Type: Article

References (14)

1. Danawati CW, Nagata M, Moriyama H, Hara K, Yasuda H, Nakayama M, et al. A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia. Diabetes Metab Res Rev 2005;21:465-9.
2. Spiegelman BM. PPAR-y: Adipogenic regulator and thiazolidinedione receptor. Diabetes 1998;47:507-14.
3. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, et al. The Pro12Ala polymorphism in PPAR-2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 2000;271:212-6.
4. Ghoussaini M, Meyre D, Lobbens S, Charpentier G, Clement K, Charles MA, et al. Implication of the Pro12Ala polymorphism of the PPAR-gamma 2 gene in type 2 diabetes and obesity in the French population. BMC Med Genet 2005;22:6-11.
5. Altshuler D, Hirschhorn JN, Klannenmark M, Lindgren CM, Vohl MC, Nemesh J, et al.The common Pro12Ala PPAR polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000;26:76-80.
6. Badii R, Bener A, Zirie M, Al-Rikabi A, Simsek M, Al-Hammaq AO, et al. Lack of association between the Pro12Ala polymorphism of the PPAR-y2 gene and type 2 diabetes mellitus in the Qatari consanguineous population. Acta Diabetol 2008;45:15-21.
7. World Health Organization, International Society of Hypertension Writing Group: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
8. Mori H, Kegami H, Kawaguchi Y, Seino S, Yokoi N, Takeda J, et al. The Pro12Ala substitution is associated with resistance to development of diabetes in the general population. Diabetes 2001;5:891-4.
9. Ringel J, Engeli S, Distler A, Sharma AM. Pro12Ala missense mutation of the peroxisome proliferator activated receptor -2 and DM. Biochem Biophys Res Commun 1999;254:450-3.
10. Sramkova D, Kunesova M, Hainer V, Hill M, Vcelak J, Bendlova B. Is a Pro12Ala polymorphism of the PPAR -2 gene related to obesity and type 2 Diabetes Mellitus in the Czech population. Ann N Y Acad Sci 2002;967:265-73.
11. Mirzaei H, Akrami SM, Golmohammadi T, Doosti M, Heshmat R, Nakhjavani M, et al. Polymorphism of Pro12Ala in the Peroxisome Proliferator-activated Receptor -2 gene in Iranian diabetic and obese subjects. Metab Syndr Relat Disord 2009;7:453-8.
12. Stumvoll M, Haring H. Perspectives in Diabetes: The Peroxisome Proliferator-Activated Receptor-2 Pro12Ala Polymorphism. Diabetes 2002;51:2341-7.
13. Zietz B, Barth N, Spiegel D, Schmitz G, Scholmerich J, Schazer A. Pro12Ala polymorphism in the Peroxisome Proliferator activated receptor gamma 2 (PPAR -2) is associated with high level of total cholesterol and LDL cholesterol in male Caucasian type 2 diabetes patients. Exp Clin Endocrinol Diabetes 2002;110:60-6.
14. Wakil SM, Al-rubean K, Alsmadi O, Imtiaz F, Carroll P, Rajab M, et al. The peroxisome and type 2 diabetes in an Arab population. Diabetes Care 2006;29:171-2.